Mark N. Feinglos, MD, CM Professor of Medicine and Chief, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC
M. Angelyn Bethel, MD Assistant Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC
Address: Mark N. Feinglos, MD, CM, Duke University Medical Center, 310A Baker House, Trent Drive, Box 3921, Durham, NC 27710; e-mail feing002@mc.duke.edu
The authors have indicated that they have received grant or research support from Aventis Pharmaceuticals.
ABSTRACTIntensive control of blood glucose reduces the incidence and progression of many of the complications of type 2 diabetes. Newer insulin formulations that approach normal physiologic patterns have made it possible to achieve glycemic goals without excessive hypoglycemia.
